You are here

Drug Forecast

Endothelin Receptor Antagonism: Focus on Bosentan

Anna Ioselevich, PharmD, Boris Nogid, PharmD, and Vitalina Rozenfeld, PharmD, BCPS
PDF version: 
This non-peptide antagonist appears to be able to improve overall left ventricular performance.